Antithrombotic treatment in atrial fibrillation

Gregory Lip, Christopher Boos

Research output: Contribution to journalArticle

6 Citations (Scopus)


Atrial fibrillation (AF) can significantly increase morbidity and mortality. It is gaining in clinical and economic importance, being the most commonly encountered tachyarrhythmia in clinical practice. Stroke is the most serious complication. Evidence from AF antithrombotic treatment trials is reviewed, risk stratification of patients with AF is discussed, and recommendations for anticoagulation are presented.
Original languageEnglish
Pages (from-to)252-8
Number of pages7
Issue number991
Publication statusPublished - 1 May 2008


Dive into the research topics of 'Antithrombotic treatment in atrial fibrillation'. Together they form a unique fingerprint.

Cite this